Table 1 Case-by-case evaluation
Patient | Gender; Age, in years | Reporter country | Co-reported events | Start date | Event date | Time to onset, in days | Co-reported drugs as potential confounders* | Co-reported drugs influencing gene transcription |
|---|---|---|---|---|---|---|---|---|
#1 | M; 79 | Japan | None | 2020-11-06 | 2023-03-17 | 862 | sitagliptin, ipragliflozin | None |
#2 | F; 87 | USA | jaundice | 2019-08-05 | 2023-02-08 | 1284 | None | raloxifene |
#3 | F; 74 | Japan | femur fracture | 2019-02-20 | 2022-08-11 | 1269 | None | bazedoxifene |